Latest News about Phase 3 Trial
Recent news which mentions Phase 3 Trial
Investors React Positively To Data From Orphazyme's Neurodegenerative Disease Candidate
August 23, 2021
Tickers
ORPH
From Benzinga
From Benzinga
DMC Recommends Biophytis Continue Sarconeos COVID-19 Study
August 16, 2021
Tickers
BPTS
From Benzinga
Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial
August 05, 2021
Tickers
VALN
From Benzinga
Sage Therapeutics Drops Two Zuranolone Depression Trials Deemed Unnecessary For Approval
August 03, 2021
Tickers
SAGE
From Benzinga
Marinus Files US Application For Ganaxolone For Genetic Epilepsy, Inks European Commercialization Pact With Orion
August 03, 2021
From Benzinga
From Benzinga
Galmed Stock Jumps As FDA Signs Off Use Of Aramchol Meglumine In Late Stage NASH Trial
August 02, 2021
Tickers
GLMD
From Benzinga
Gilead's Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients
July 19, 2021
Tickers
GILD
From Benzinga
From Benzinga
Alexion's Ultomiris Shows Compelling, Durable Efficacy In Rare Muscle Weakness Disorder
July 16, 2021
Tickers
ALXN
From Benzinga
Theratechnologies In Search Of Potential Partner For Late-Stage NASH Study Of Tesamorelin, Reports Q2 Earnings
July 15, 2021
Tickers
THTX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
